14C-Bleximenib (Radiolabeled)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 14C-Bleximenib (Radiolabeled), covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia [Phase 1]